Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cryopyrin-Associated Periodic Syndrome”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Testing effectiveness (Phase 2)Ended earlyNCT04524858
What this trial is testing

Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)

Who this might be right for
Cryopyrin-Associated Periodic Syndrome
Aclaris Therapeutics, Inc. 1
Not applicableStudy completedNCT00887939
What this trial is testing

Pathogenesis of Physical Induced Urticarial Syndromes

Who this might be right for
Hypersensitivity, ImmediateAutoinflammatory SyndromesPhysical Urticaria+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 173
Testing effectiveness (Phase 2)Study completedNCT05186051
What this trial is testing

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS)

Who this might be right for
Cryopyrin Associated Periodic Syndrome
Zydus Lifesciences Limited 3
Large-scale testing (Phase 3)Study completedNCT01302860
What this trial is testing

Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Who this might be right for
Cryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more
Novartis Pharmaceuticals 17
Not applicableEnded earlyNCT03219918
What this trial is testing

Adenoma Detection Rate in Colonoscopy Performed With EndoRings

Who this might be right for
Colorectal AdenomaColorectal Neoplasms
Zealand University Hospital 97
Not applicableLooking for participantsNCT06544018
What this trial is testing

Circadian Rhythm Deregulation in Patients With CAPS

Who this might be right for
Cryopyrin Associated Periodic SyndromeFamilial Cold UrticariaMuckle-Wells Syndrome+1 more
Hospices Civils de Lyon 30
Large-scale testing (Phase 3)Ended earlyNCT00770601
What this trial is testing

Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease

Who this might be right for
NOMIDCINCA Syndrome
Novartis Pharmaceuticals 7
Not applicableUnknownNCT03566615
What this trial is testing

Does the Cap Increase the Finding of Polyps When Water Exchange Colonoscopy is Used

Who this might be right for
ColonoscopyPolyp of Colon
VA Greater Los Angeles Healthcare System 1,630
Not applicableStudy completedNCT01213641
What this trial is testing

Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients

Who this might be right for
Cryopyrin-associated Periodic Syndromes (CAPS)Familial Cold Autoinflam Syn (FCAS)Muckle-wells Syn (MWS)+1 more
Novartis Pharmaceuticals 288
Large-scale testing (Phase 3)Study completedNCT00991146
What this trial is testing

Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase

Who this might be right for
Cryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more
Novartis Pharmaceuticals 19
Testing effectiveness (Phase 2)Study completedNCT05812781
What this trial is testing

Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome

Who this might be right for
Cryopyrin Associated Periodic Syndrome
Zomagen Biosciences Ltd. 7
Testing effectiveness (Phase 2)Study completedNCT01045772
What this trial is testing

Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)

Who this might be right for
Muckle-Wells SyndromeSchnitzler Syndrome
Charite University, Berlin, Germany 10
Early research (Phase 1)Study completedNCT02175056
What this trial is testing

A Dose-Block Randomized, Placebo Controlled (Double-blind), Active Controlled(Open-label), Dose-escalation Study

Who this might be right for
Healthy Volunteers
Handok Inc. 58
Large-scale testing (Phase 3)Study completedNCT02334748
What this trial is testing

Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies

Who this might be right for
Systemic Juvenile Idiopathic ArthritisHereditary Periodic Fevers
Novartis Pharmaceuticals 31
Testing effectiveness (Phase 2)Ended earlyNCT02853084
What this trial is testing

HL2351 CAPS Phase II Study

Who this might be right for
Cryopyrin-Associated Periodic Syndromes (CAPS)
Handok Inc. 8
Not applicableStudy completedNCT02326376
What this trial is testing

Kineret CAPS Post Authorisation Study

Who this might be right for
Cryopyrin-Associated Periodic Syndromes
Swedish Orphan Biovitrum 12
Large-scale testing (Phase 3)Study completedNCT01105507
What this trial is testing

The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada

Who this might be right for
Cryopyrin Associated Periodic Syndrome
Novartis Pharmaceuticals 4
Not applicableStudy completedNCT04856540
What this trial is testing

Adult Outcomes of Children With CAPS

Who this might be right for
Cryopyrin Associated Periodic Syndrome
University Hospital, Lille 54
Early research (Phase 1)Study completedNCT04015076
What this trial is testing

Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With Inzomelid

Who this might be right for
Healthy
Inflazome UK Ltd 80
Large-scale testing (Phase 3)Study completedNCT01576367
What this trial is testing

Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Who this might be right for
Cryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more
Novartis Pharmaceuticals 17
Next Page